Literature DB >> 8811337

Predominance of defective proviral sequences in an HIV + long-term non-progressor.

D H Schwartz1, R Viscidi, O Laeyendecker, H Song, S C Ray, N Michael.   

Abstract

We examined the accessory genes and envelope V3 region of provirus obtained over a 5 year period from an HIV+ long-term non-progressor with very low viral load and no in vitro recoverable virus during that same time span. LTR sequences supported normal Tat-mediated promoter activity. Multiple clones of nef sequences were highly conserved with < 10% containing frame shift or stop codon mutations. Functional analysis of the predominant nef sequence indicated wild type downregulation of surface CD4 and good function in a complementation infectivity assay. By contrast, inactivating mutations were found in 64% of amplicons containing vif, vpr, vpu, tat1, and rev1, and in 41% of amplicons containing env V3. Identical inactive sequences were obtained at an interval of 2 years, suggesting persistence of quiescent defective provirus in a long-lived clonal cell population. Furthermore, genetic distance versus time analysis revealed an absence of progressive evolution or arborization of quasispecies over time. This contrasts with data generated from other asymptomatic HIV+ individuals. The non-progressive pattern of env sequence diversity and low R2 for genetic divergence over time suggests that the defective provirus circulating in the periphery of this patient represents a randomly sampled 'fossil record' of earlier replication competent HIV-1 genomes.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8811337     DOI: 10.1016/0165-2478(96)02547-3

Source DB:  PubMed          Journal:  Immunol Lett        ISSN: 0165-2478            Impact factor:   3.685


  7 in total

Review 1.  Antiretroviral therapy : optimal sequencing of therapy to avoid resistance.

Authors:  Jorge L Martinez-Cajas; Mark A Wainberg
Journal:  Drugs       Date:  2008       Impact factor: 9.546

2.  Immunogenicity of a lentiviral-based DNA vaccine driven by the 5'LTR of the naturally attenuated caprine arthritis encephalitis virus (CAEV) in mice and macaques.

Authors:  Géraldine Arrode-Brusés; Ramakrishna Hegde; Yuhuai Jin; Zhengian Liu; Opendra Narayan; Yahia Chebloune
Journal:  Vaccine       Date:  2012-03-02       Impact factor: 3.641

3.  Intra-host competition between nef-defective escape mutants and wild-type human immunodeficiency virus type 1.

Authors:  H K Altes; V A Jansen
Journal:  Proc Biol Sci       Date:  2000-01-22       Impact factor: 5.349

4.  Genetic and functional diversity of human immunodeficiency virus type 1 subtype B Nef primary isolates.

Authors:  J L Foster; R P Molina; T Luo; V K Arora; Y Huang; D D Ho; J V Garcia
Journal:  J Virol       Date:  2001-02       Impact factor: 5.103

5.  How Escherichia coli can bias the results of molecular cloning: preferential selection of defective genomes of hepatitis C virus during the cloning procedure.

Authors:  X Forns; J Bukh; R H Purcell; S U Emerson
Journal:  Proc Natl Acad Sci U S A       Date:  1997-12-09       Impact factor: 11.205

6.  Construction and in vitro properties of a series of attenuated simian immunodeficiency viruses with all accessory genes deleted.

Authors:  Y Guan; J B Whitney; M Detorio; M A Wainberg
Journal:  J Virol       Date:  2001-05       Impact factor: 5.103

7.  Long-term central and effector SHIV-specific memory T cell responses elicited after a single immunization with a novel lentivector DNA vaccine.

Authors:  Géraldine Arrode-Brusés; Maha Moussa; Monique Baccard-Longere; François Villinger; Yahia Chebloune
Journal:  PLoS One       Date:  2014-10-22       Impact factor: 3.240

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.